To date, there have been four observational studies investigating the topical application of 0.1% vitamin K1 cream, three reactive 58–60 and one prophylactic.61 In all three reactive studies good control of EGFR-targeted therapy-induced rash was observed. Here, EGFR is linked to exanthem.